Skip to content
Search

Latest Stories

Grey’s Anatomy and Euphoria star Eric Dane diagnosed with ALS

Amyotrophic lateral sclerosis (ALS) also known as motor neurone disease

Eric Dane

There is currently no cure for ALS

Getty

Eric Dane, best known for his roles in Grey’s Anatomy and Euphoria, has revealed he has been diagnosed with amyotrophic lateral sclerosis (ALS).

ALS, also referred to as motor neurone disease (MND) in the UK, is an incurable condition that progressively damages nerve cells in the brain and spinal cord, leading to increasing muscle paralysis. The disease affects around 153,000 people in the UK, though awareness of its wider range of symptoms remains relatively low.


Despite his diagnosis, Dane, 52, confirmed he will continue working on the third season of HBO’s Euphoria, in which he plays Cal Jacobs. Speaking to People magazine, Dane said: "I have been diagnosed with ALS. I am grateful to have my loving family by my side as we navigate this next chapter. I feel fortunate that I am able to continue working and am looking forward to returning to [the] set of Euphoria next week. I kindly ask that you give my family and I privacy during this time."

According to the US National Institute of Neurological Disorders and Stroke (NINDS), early symptoms of ALS include muscle twitches in the arms, legs, shoulders or tongue, muscle cramps, stiffness, weakness, slurred or nasal speech, and difficulty chewing or swallowing.

ALS was first identified by French neurologist Jean-Martin Charcot in 1869. It is also widely known as Lou Gehrig’s disease in the United States, named after the famous New York Yankees baseball player who died from the condition in 1941.

There is currently no cure for ALS. However, several treatments have been approved to help manage symptoms and potentially slow progression. These include Riluzole, which reduces damage to motor neurons, and Radicava, which may slow the decline of physical function.

The prognosis for ALS patients varies significantly. On average, individuals live around 27 months following diagnosis. However, some, like renowned physicist Stephen Hawking, survive for decades. Hawking was diagnosed with a slow-progressing form of the disease at the age of 21 and lived until he was 76.

ALS can affect anyone, but it is most commonly diagnosed in people aged between 55 and 75. Some studies have suggested that former military personnel are at higher risk, potentially due to exposure to environmental toxins during service, though the evidence remains inconclusive.

Genetic factors also play a role in a minority of cases. The ALS Association reports that around 90 per cent of cases have no known family history. In the 5 to 10 per cent where a hereditary link is identified, there is about a 50 per cent chance of the gene mutation being passed on.

Away from his career, Dane shares two daughters, Billie, 15, and Georgia, 13, with actress and model Rebecca Gayheart. Last month, Gayheart confirmed that she and Dane had decided to call off their divorce, which had been filed after 14 years of marriage. Speaking to E! News, Gayheart said the couple had "really figured out the formula to staying a family," adding that both they and their children were "benefiting greatly" from the arrangement.

Dane rose to fame through his portrayal of Dr Mark Sloan, also known as “McSteamy,” in Grey’s Anatomy, and has since become a familiar face in both television and film. His role in Euphoria has been praised for its complexity and emotional depth, and his commitment to continue working has been met with widespread support from fans and colleagues alike.

More For You

weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
Weight Loss Drug

Health officials expect the rollout to benefit around 220,000 adults over the next 3 years

iStock

NHS GPs to prescribe Mounjaro in nationwide obesity treatment plan

Key points

  • NHS GPs in England can now prescribe Mounjaro (tirzepatide) for weight loss
  • The programme aims to support 220,000 people over three years
  • Eligible patients must have a BMI over 40 and at least four obesity-related health issues
  • GP leaders raise concerns over increased workload
  • Pharmacists urge a broader weight management approach

NHS expands obesity treatment with Mounjaro

The NHS in England is set to begin prescribing Mounjaro, a weight loss injection, through GP surgeries starting Monday. The move marks the first time family doctors will be authorised to directly prescribe the anti-obesity drug tirzepatide as part of a wider national health initiative.

Health officials expect the rollout to benefit around 220,000 adults over the next three years. The drug will be made available to those with a body mass index (BMI) above 40 who also suffer from at least four other obesity-related conditions, such as type 2 diabetes, high blood pressure, or sleep apnoea.

Keep ReadingShow less
UK heatwave deaths

Around 85% of the projected deaths are likely to involve people over the age of 65

iStock

Scientists warn current UK heatwave may cause nearly 600 early deaths

Almost 600 premature deaths are expected to occur during the ongoing heatwave affecting England and Wales, according to a new rapid analysis by leading scientists. The majority of fatalities are projected among older adults, with London and the West Midlands likely to be the worst-affected areas.

Climate change driving deadly temperatures

Researchers say the extreme temperatures, which have reached 32°C in parts of south-east England, would have been nearly impossible without the influence of human-caused climate change. Pollution from burning fossil fuels has raised the likelihood of such heatwaves by around 100 times, experts say.

Keep ReadingShow less
Amycretin

'The Lancet' and presentations at the American Diabetes Association’s 2025

iStock

New weight-loss pill Amycretin shows greater impact than jabs, study finds

A new weight-loss drug, amycretin, has delivered the most significant results yet for appetite-suppressing GLP-1 medications, according to two newly published studies in The Lancet and presentations at the American Diabetes Association’s 2025 Scientific Sessions in Chicago.

Record weight loss from Amycretin injections

Researchers found that participants receiving high-dose weekly injections of amycretin lost 24.3 per cent of their body weight over 36 weeks. This outcome surpasses the results seen in longer trials involving other GLP-1 drugs such as tirzepatide (sold as Mounjaro), which previously led the field with an average weight loss of 20 per cent over 72 weeks.

Keep ReadingShow less
Hulk Hogan

Hogan’s current hospital stay follows a neck fusion surgery he underwent in May 2025

Getty Images

Hulk Hogan hospitalised for back and neck issues, rep confirms he is not on deathbed

WWE Hall of Famer Hulk Hogan has been hospitalised for ongoing neck and back issues, but representatives have confirmed he is not in critical condition, dismissing online speculation suggesting otherwise.

The 71-year-old wrestling icon, whose real name is Terry Bollea, was reported by TMZ Sports to be undergoing treatment related to injuries sustained during his decades-long in-ring career. His representative said Hogan is already mobile again and “not on his deathbed”, following false claims made on air by Florida radio personality Bubba the Love Sponge.

Keep ReadingShow less